117 related articles for article (PubMed ID: 38842335)
1. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
J Virol; 2024 Jun; ():e0067924. PubMed ID: 38842335
[TBL] [Abstract][Full Text] [Related]
2. The chikungunya virus E1 glycoprotein fusion loop and hinge alter glycoprotein dynamics leading to cell and host specific changes in infectivity.
Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
bioRxiv; 2023 Nov; ():. PubMed ID: 37961096
[TBL] [Abstract][Full Text] [Related]
3. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
4. Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.
Sahoo B; Gudigamolla NK; Chowdary TK
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938768
[TBL] [Abstract][Full Text] [Related]
5. Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
Lucas CJ; Davenport BJ; Carpentier KS; Tinega AN; Morrison TE
J Virol; 2022 May; 96(9):e0006422. PubMed ID: 35416719
[TBL] [Abstract][Full Text] [Related]
6. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
[TBL] [Abstract][Full Text] [Related]
7. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
bioRxiv; 2023 Feb; ():. PubMed ID: 36865275
[TBL] [Abstract][Full Text] [Related]
8. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
9. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry.
Sahoo B; Chowdary TK
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876
[TBL] [Abstract][Full Text] [Related]
11. Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.
Rangel MV; Catanzaro N; Thannickal SA; Crotty KA; Noval MG; Johnson KEE; Ghedin E; Lazear HM; Stapleford KA
J Virol; 2022 Jan; 96(2):e0177421. PubMed ID: 34757841
[TBL] [Abstract][Full Text] [Related]
12. Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.
Tsetsarkin KA; McGee CE; Volk SM; Vanlandingham DL; Weaver SC; Higgs S
PLoS One; 2009 Aug; 4(8):e6835. PubMed ID: 19718263
[TBL] [Abstract][Full Text] [Related]
13. Mutations at the Alphavirus E1'-E2 Interdimer Interface Have Host-Specific Phenotypes.
Ren SC; Qazi SA; Towell B; Wang JC; Mukhopadhyay S
J Virol; 2022 Mar; 96(5):e0214921. PubMed ID: 35019719
[TBL] [Abstract][Full Text] [Related]
14. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Molecular Surveillance of Chikungunya Virus.
Fischer C; de Lamballerie X; Drexler JF
mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of Getah Virus by a Single Amino Acid Substitution at Residue 253 of the E2 Protein that Might Be Part of a New Heparan Sulfate Binding Site on Alphaviruses.
Wang N; Zhai X; Li X; Wang Y; He WT; Jiang Z; Veit M; Su S
J Virol; 2022 Mar; 96(6):e0175121. PubMed ID: 34986000
[TBL] [Abstract][Full Text] [Related]
18. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
19. Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope Protein.
Song H; Zhao Z; Chai Y; Jin X; Li C; Yuan F; Liu S; Gao Z; Wang H; Song J; Vazquez L; Zhang Y; Tan S; Morel CM; Yan J; Shi Y; Qi J; Gao F; Gao GF
Cell; 2019 Jun; 177(7):1714-1724.e12. PubMed ID: 31080063
[TBL] [Abstract][Full Text] [Related]
20. Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.
Zimmerman O; Zimmerman MI; Raju S; Nelson CA; Errico JM; Madden EA; Holmes AC; Hassan AO; VanBlargan LA; Kim AS; Adams LJ; Basore K; Whitener BM; Palakurty S; Davis-Adams HG; Sun C; Gilliland T; Earnest JT; Ma H; Ebel GD; Zmasek C; Scheuermann RH; Klimstra WB; Fremont DH; Diamond MS
Cell; 2023 Oct; 186(22):4818-4833.e25. PubMed ID: 37804831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
